COVID-19 patients commonly report having headaches, confusion and other neurological symptoms, but doctors don't fully understand how the disease targets the brain during infection.
Apr 1, 2022
0
205
A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive impairment—are ultimately reversible, according to new research summarized by the Journal of Nuclear Medicine. The ...
Mar 17, 2022
0
101
Seven in ten long COVID patients experience concentration and memory problems several months after the initial onset of their disease, with many performing worse than their peers on cognitive tests, according to new research ...
Mar 17, 2022
0
63
(HealthDay)—Following a bout of severe COVID-19, some children suffer lasting neurological complications, part of a rare condition called multisystem inflammatory syndrome in children (MIS-C), a new study finds.
Feb 3, 2022
0
52
Even after antibiotic treatment, some Lyme disease patients suffer from an array of symptoms including neurological issues that greatly diminish their quality of life. Brain scans of these patients show persistent neuroinflammation, ...
Jan 27, 2022
0
168
The blood-brain barrier keeps foreign substances from entering the brain. That's good when it comes to toxins and germs, but it makes treating tumors in the brain trickier. By shielding the brain from things that would harm ...
Jan 26, 2022
0
6
Of hospitalized children who tested or were presumed positive for SARS-CoV-2, 44% developed neurological symptoms, and these kids were more likely to require intensive care than their peers who didn't experience such symptoms, ...
Jan 21, 2022
0
312
SARS-CoV-2 was initially identified as a respiratory virus, but it can affect the entire body, including the nervous system. In a new Viewpoint published in Science, Avindra Nath, M.D., clinical director of the National Institutes ...
Jan 20, 2022
0
319
Patients hospitalized for COVID-19 had higher levels over the short term of blood proteins known to rise with neurological damage than non-COVID-19 patients diagnosed with Alzheimer's disease, a new study finds.
Jan 13, 2022
0
13
Research from a University of Saskatchewan (USask) College of Medicine team will help develop medications that can inhibit the nerve cell damage that occurs due to diseases such as multiple sclerosis (MS).
Nov 1, 2021
0
136
